Zhu FC, Guan XH, Li YH, Huang JY, et al. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 2020 Jul 20. pii: S0140-6736(20)31605.
PMID: 32702299